The Economic Times

UC innovations make TIMEs Best Inventions of 2026: How a pancreatic cancer drug and smarter wheelchair are changing lives?

From a pancreatic cancer drug that targets KRAS mutations to a smarter power wheelchair, University of California research is reaching beyond laboratories. Daraxonrasib, developed from discoveries at UCSF, received FDA approval in August. Meanwhile, UC Berkeley alumnus Tony Hongs Strutt ev uses sensors and voice controls to make everyday mobility easier.